Table of Content

1 Cyclizine Market Overview
1.1 Product Overview and Scope of Cyclizine
1.2 Cyclizine Segment by Type
1.2.1 Global Cyclizine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Oral
1.2.3 Injection
1.3 Cyclizine Segment by Application
1.3.1 Cyclizine Sales Comparison by Application: (2021-2027)
1.3.2 Migraine
1.3.3 Motion Sickness
1.4 Global Cyclizine Market Size Estimates and Forecasts
1.4.1 Global Cyclizine Revenue 2016-2027
1.4.2 Global Cyclizine Sales 2016-2027
1.4.3 Cyclizine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cyclizine Market Competition by Manufacturers
2.1 Global Cyclizine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Cyclizine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Cyclizine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Cyclizine Manufacturing Sites, Area Served, Product Type
2.5 Cyclizine Market Competitive Situation and Trends
2.5.1 Cyclizine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Cyclizine Players Market Share by Revenue
2.5.3 Global Cyclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cyclizine Retrospective Market Scenario by Region
3.1 Global Cyclizine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Cyclizine Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Cyclizine Market Facts & Figures by Country
3.3.1 North America Cyclizine Sales by Country
3.3.2 North America Cyclizine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Cyclizine Market Facts & Figures by Country
3.4.1 Europe Cyclizine Sales by Country
3.4.2 Europe Cyclizine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Cyclizine Market Facts & Figures by Region
3.5.1 Asia Pacific Cyclizine Sales by Region
3.5.2 Asia Pacific Cyclizine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Cyclizine Market Facts & Figures by Country
3.6.1 Latin America Cyclizine Sales by Country
3.6.2 Latin America Cyclizine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Cyclizine Market Facts & Figures by Country
3.7.1 Middle East and Africa Cyclizine Sales by Country
3.7.2 Middle East and Africa Cyclizine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Cyclizine Historic Market Analysis by Type
4.1 Global Cyclizine Sales Market Share by Type (2016-2021)
4.2 Global Cyclizine Revenue Market Share by Type (2016-2021)
4.3 Global Cyclizine Price by Type (2016-2021)

5 Global Cyclizine Historic Market Analysis by Application
5.1 Global Cyclizine Sales Market Share by Application (2016-2021)
5.2 Global Cyclizine Revenue Market Share by Application (2016-2021)
5.3 Global Cyclizine Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Amoun Pharmaceutical
6.1.1 Amoun Pharmaceutical Corporation Information
6.1.2 Amoun Pharmaceutical Description and Business Overview
6.1.3 Amoun Pharmaceutical Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Amoun Pharmaceutical Product Portfolio
6.1.5 Amoun Pharmaceutical Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Corporation Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glaxosmithkline Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Pharmascript Limited
6.3.1 Pharmascript Limited Corporation Information
6.3.2 Pharmascript Limited Description and Business Overview
6.3.3 Pharmascript Limited Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Pharmascript Limited Product Portfolio
6.3.5 Pharmascript Limited Recent Developments/Updates
6.4 Advanz Pharma
6.4.1 Advanz Pharma Corporation Information
6.4.2 Advanz Pharma Description and Business Overview
6.4.3 Advanz Pharma Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Advanz Pharma Product Portfolio
6.4.5 Advanz Pharma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Corporation Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Teva Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 P and D Pharmaceuticals
6.6.1 P and D Pharmaceuticals Corporation Information
6.6.2 P and D Pharmaceuticals Description and Business Overview
6.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 P and D Pharmaceuticals Product Portfolio
6.6.5 P and D Pharmaceuticals Recent Developments/Updates
6.7 Wabosan Arzneimittel
6.6.1 Wabosan Arzneimittel Corporation Information
6.6.2 Wabosan Arzneimittel Description and Business Overview
6.6.3 Wabosan Arzneimittel Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Wabosan Arzneimittel Product Portfolio
6.7.5 Wabosan Arzneimittel Recent Developments/Updates
6.8 Aspen Pharmacare
6.8.1 Aspen Pharmacare Corporation Information
6.8.2 Aspen Pharmacare Description and Business Overview
6.8.3 Aspen Pharmacare Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Aspen Pharmacare Product Portfolio
6.8.5 Aspen Pharmacare Recent Developments/Updates
6.9 Amco
6.9.1 Amco Corporation Information
6.9.2 Amco Description and Business Overview
6.9.3 Amco Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Amco Product Portfolio
6.9.5 Amco Recent Developments/Updates
6.10 Aft Pharmaceuticals
6.10.1 Aft Pharmaceuticals Corporation Information
6.10.2 Aft Pharmaceuticals Description and Business Overview
6.10.3 Aft Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Aft Pharmaceuticals Product Portfolio
6.10.5 Aft Pharmaceuticals Recent Developments/Updates
6.11 Be-Tabs Pharmaceuticals
6.11.1 Be-Tabs Pharmaceuticals Corporation Information
6.11.2 Be-Tabs Pharmaceuticals Cyclizine Description and Business Overview
6.11.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Be-Tabs Pharmaceuticals Product Portfolio
6.11.5 Be-Tabs Pharmaceuticals Recent Developments/Updates
6.12 Wockhardt UK
6.12.1 Wockhardt UK Corporation Information
6.12.2 Wockhardt UK Cyclizine Description and Business Overview
6.12.3 Wockhardt UK Cyclizine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Wockhardt UK Product Portfolio
6.12.5 Wockhardt UK Recent Developments/Updates

7 Cyclizine Manufacturing Cost Analysis
7.1 Cyclizine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Cyclizine
7.4 Cyclizine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Cyclizine Distributors List
8.3 Cyclizine Customers

9 Cyclizine Market Dynamics
9.1 Cyclizine Industry Trends
9.2 Cyclizine Growth Drivers
9.3 Cyclizine Market Challenges
9.4 Cyclizine Market Restraints

10 Global Market Forecast
10.1 Cyclizine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Cyclizine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Cyclizine by Type (2022-2027)
10.2 Cyclizine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Cyclizine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Cyclizine by Application (2022-2027)
10.3 Cyclizine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Cyclizine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Cyclizine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Cyclizine Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Cyclizine Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Cyclizine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Cyclizine Covered in This Study
Table 5. Global Cyclizine Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Cyclizine Sales Share by Manufacturers (2016-2021)
Table 7. Global Cyclizine Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Cyclizine Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Cyclizine Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Cyclizine Manufacturing Sites and Area Served
Table 11. Manufacturers Cyclizine Product Type
Table 12. Global Cyclizine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Cyclizine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cyclizine as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Cyclizine Sales by Region (2016-2021) & (K Units)
Table 16. Global Cyclizine Sales Market Share by Region (2016-2021)
Table 17. Global Cyclizine Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Cyclizine Sales by Country (2016-2021) & (K Units)
Table 19. North America Cyclizine Sales Market Share by Country (2016-2021)
Table 20. North America Cyclizine Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Cyclizine Revenue Market Share by Country (2016-2021)
Table 22. Europe Cyclizine Sales by Country (2016-2021) & (K Units)
Table 23. Europe Cyclizine Sales Market Share by Country (2016-2021)
Table 24. Europe Cyclizine Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Cyclizine Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Cyclizine Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Cyclizine Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Cyclizine Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Cyclizine Revenue Market Share by Region (2016-2021)
Table 30. Latin America Cyclizine Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Cyclizine Sales Market Share by Country (2016-2021)
Table 32. Latin America Cyclizine Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Cyclizine Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Cyclizine Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Cyclizine Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Cyclizine Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Cyclizine Revenue Market Share by Country (2016-2021)
Table 38. Global Cyclizine Sales (K Units) by Type (2016-2021)
Table 39. Global Cyclizine Sales Market Share by Type (2016-2021)
Table 40. Global Cyclizine Revenue (Million US$) by Type (2016-2021)
Table 41. Global Cyclizine Revenue Share by Type (2016-2021)
Table 42. Global Cyclizine Price (US$/Unit) by Type (2016-2021)
Table 43. Global Cyclizine Sales (K Units) by Application (2016-2021)
Table 44. Global Cyclizine Sales Market Share by Application (2016-2021)
Table 45. Global Cyclizine Revenue (Million US$) by Application (2016-2021)
Table 46. Global Cyclizine Revenue Share by Application (2016-2021)
Table 47. Global Cyclizine Price (US$/Unit) by Application (2016-2021)
Table 48. Amoun Pharmaceutical Corporation Information
Table 49. Amoun Pharmaceutical Description and Business Overview
Table 50. Amoun Pharmaceutical Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Amoun Pharmaceutical Cyclizine Product
Table 52. Amoun Pharmaceutical Recent Developments/Updates
Table 53. Glaxosmithkline Corporation Information
Table 54. Glaxosmithkline Description and Business Overview
Table 55. Glaxosmithkline Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Glaxosmithkline Cyclizine Product
Table 57. Glaxosmithkline Recent Developments/Updates
Table 58. Pharmascript Limited Corporation Information
Table 59. Pharmascript Limited Description and Business Overview
Table 60. Pharmascript Limited Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Pharmascript Limited Cyclizine Product
Table 62. Pharmascript Limited Recent Developments/Updates
Table 63. Advanz Pharma Corporation Information
Table 64. Advanz Pharma Description and Business Overview
Table 65. Advanz Pharma Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Advanz Pharma Cyclizine Product
Table 67. Advanz Pharma Recent Developments/Updates
Table 68. Teva Corporation Information
Table 69. Teva Description and Business Overview
Table 70. Teva Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Teva Cyclizine Product
Table 72. Teva Recent Developments/Updates
Table 73. P and D Pharmaceuticals Corporation Information
Table 74. P and D Pharmaceuticals Description and Business Overview
Table 75. P and D Pharmaceuticals Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. P and D Pharmaceuticals Cyclizine Product
Table 77. P and D Pharmaceuticals Recent Developments/Updates
Table 78. Wabosan Arzneimittel Corporation Information
Table 79. Wabosan Arzneimittel Description and Business Overview
Table 80. Wabosan Arzneimittel Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Wabosan Arzneimittel Cyclizine Product
Table 82. Wabosan Arzneimittel Recent Developments/Updates
Table 83. Aspen Pharmacare Corporation Information
Table 84. Aspen Pharmacare Description and Business Overview
Table 85. Aspen Pharmacare Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Aspen Pharmacare Cyclizine Product
Table 87. Aspen Pharmacare Recent Developments/Updates
Table 88. Amco Corporation Information
Table 89. Amco Description and Business Overview
Table 90. Amco Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Amco Cyclizine Product
Table 92. Amco Recent Developments/Updates
Table 93. Aft Pharmaceuticals Corporation Information
Table 94. Aft Pharmaceuticals Description and Business Overview
Table 95. Aft Pharmaceuticals Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Aft Pharmaceuticals Cyclizine Product
Table 97. Aft Pharmaceuticals Recent Developments/Updates
Table 98. Be-Tabs Pharmaceuticals Corporation Information
Table 99. Be-Tabs Pharmaceuticals Description and Business Overview
Table 100. Be-Tabs Pharmaceuticals Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Be-Tabs Pharmaceuticals Cyclizine Product
Table 102. Be-Tabs Pharmaceuticals Recent Developments/Updates
Table 103. Wockhardt UK Corporation Information
Table 104. Wockhardt UK Description and Business Overview
Table 105. Wockhardt UK Cyclizine Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Wockhardt UK Cyclizine Product
Table 107. Wockhardt UK Recent Developments/Updates
Table 108. Production Base and Market Concentration Rate of Raw Material
Table 109. Key Suppliers of Raw Materials
Table 110. Cyclizine Distributors List
Table 111. Cyclizine Customers List
Table 112. Cyclizine Market Trends
Table 113. Cyclizine Growth Drivers
Table 114. Cyclizine Market Restraints
Table 115. Global Cyclizine Sales Forecast by Type (2022-2027) & (K Units)
Table 116. Global Cyclizine Sales Market Share Forecast by Type (2022-2027)
Table 117. Global Cyclizine Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 118. Global Cyclizine Revenue Market Share Forecast by Type (2022-2027)
Table 119. Global Cyclizine Sales Forecast by Application (2022-2027) & (K Units)
Table 120. Global Cyclizine Sales Market Share Forecast by Application (2022-2027)
Table 121. Global Cyclizine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 122. Global Cyclizine Revenue Market Share Forecast by Application (2022-2027)
Table 123. Global Cyclizine Sales Forecast by Region (2022-2027) & (K Units)
Table 124. Global Cyclizine Sales Market Share Forecast by Region (2022-2027)
Table 125. Global Cyclizine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 126. Global Cyclizine Revenue Market Share Forecast by Region (2022-2027)
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cyclizine
Figure 2. Global Cyclizine Market Share by Type in 2020 & 2027
Figure 3. Oral Product Picture
Figure 4. Injection Product Picture
Figure 5. Global Cyclizine Market Share by Application in 2020 & 2027
Figure 6. Migraine
Figure 7. Motion Sickness
Figure 8. Global Cyclizine Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Cyclizine Market Size 2016-2027 (US$ Million)
Figure 10. Global Cyclizine Sales 2016-2027 (K Units)
Figure 11. Global Cyclizine Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Cyclizine Sales Share by Manufacturers in 2020
Figure 13. Global Cyclizine Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Cyclizine Players: Market Share by Revenue in 2020
Figure 15. Cyclizine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Cyclizine Sales Market Share by Region (2016-2021)
Figure 17. Global Cyclizine Sales Market Share by Region in 2020
Figure 18. Global Cyclizine Revenue Market Share by Region (2016-2021)
Figure 19. Global Cyclizine Revenue Market Share by Region in 2020
Figure 20. U.S. Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Cyclizine Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Cyclizine by Type (2016-2021)
Figure 45. Sales Market Share of Cyclizine by Application (2016-2021)
Figure 46. Sales Market Share of Cyclizine by Application in 2020
Figure 47. Revenue Share of Cyclizine by Application (2016-2021)
Figure 48. Revenue Share of Cyclizine by Application in 2020
Figure 49. Manufacturing Cost Structure of Cyclizine
Figure 50. Manufacturing Process Analysis of Cyclizine
Figure 51. Cyclizine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed